It’s Libre, Man! In-Depth Review of the Newly Approved Freestyle Libre

/, Thinking Like A Pancreas Blog/It’s Libre, Man! In-Depth Review of the Newly Approved Freestyle Libre
Facebooktwittergoogle_plusredditlinkedinmail

Diabetes educator, Gary Scheiner gives his in-depth review of the newly approved Abbott Freestyle Libre CGM continuous glucose monitor.

Faster than the fastest meter.

More powerful than point-in-time measurements.

Able to leap piles of test strips with a single scan.

 

Look… on pharmacy shelves (soon).  It’s a meter.  It’s a CGM.  It’s FREESTYLE LIBRE!

 

Seriously, this is exciting.  Abbott’s Frestyle Libre has finally been approved for sale in the United States.  Why the excitement?  Because it almost eliminates the need for fingerstick blood glucose measurements.  It has features of a CGM (continuous glucose monitor) and a blood glucose meter combined in one device.  And it is simple to use, reasonably accurate, virtually painless, and relatively inexpensive ($60 for the durable receiver/scanner, $40 per sensor; insurance coverage pending).

 

Super!  How does it work?

 

An applicator device is placed on the back of the arm.  With one push, a tiny glucose-sensitive filament is inserted just below the skin, with the waterproof transmitter (about the size of two stacked quarters) attached and adhered to the skin.  After a 12-hour warmup period, a signal is sent every minute to a handheld receiver about the size of a small cell phone, and the current glucose level along with a trend arrow and graph of the most recent eight hours of data is displayed.  The sensor/transmitter is replaced every 10 days.  And because of its accuracy, NO fingerstick calibrations are required.

 

 

A very similar device has been available in Europe and other parts of the world since 2014.  The hardware is basically the same, but there are a few subtle differences between the US version and the European version.  The European sensors last 14 days each as opposed to 10 with the US version (the sensors cannot be “re-used”), and the warmup period only lasts 1 hour (as opposed to 12).  However, the accuracy of the US version is slightly better (average error of 9.7%, compared to 11%) – likely due to the longer warmup and shorter length of wear.  Also nice to know that the sensors are not affected by acetaminophen.

 

Everyone at our practice had a chance to try out the European version of Freestyle Libre soon after it launched (it helps to have friendly clients all over the world!).  We were impressed with it from the getgo.  Compared to current CGM systems, it is very easy to insert and use right out of the box.  No training required.  Despite the lack of fingerstick calibrations, the data generally matched up well to our fingerstick meter readings (you didn’t think we would trust it THAT much, did you?). The comfort was also quite good, although the adhesive left a little to be desired.

 

OK… What’s the Kryptonite?

 

My pappy once told me that if something sounds too good to be true, it probably is.  While Freestyle Libre combines many of the features of CGM and fingerstick meters, it comes up short in a number of key areas.  Perhaps the most glaring weakness is the lack of alarms/alerts for pending high and low glucose levels.  Because the user has to physically “scan” the receiver just over the transmitter in order to generate any data, the device does not track things constantly the way a Dexcom or Medtronic sensor does.  The only way to know if you’re low or heading low is to do a scan.  With so many people lacking early warning symptoms for low blood glucose, traditional CGMs are relied upon heavily for avoidance of significant hypoglycemia.  Libre may help users cut down on the frequency and severity of lows, but only if the user scans the sensor every 5-10 minutes, including through the night.  And that’s just not about to happen.

 

Libre also lacks the ability to transmit data to a cell phone or to “share” the data electronically with loved ones and caregivers.  This will likely change over the next several years, but for the time being, the only person who can see what’s going on is the one who is scanning the sensor.

 

And how does Libre stack up to our trusty, dusty blood glucose meters?  Sure, Libre has been approved as a replacement for fingersticks, but does that mean it should be?  Remember, on average, Libre is about 10% off from reference (lab) values.  That about matches many older-generation meters that are currently on the market.  Today’s latest meters, such as the Contour Next, Freestyle Lite, Dario and AccuCheck Nano are far more accurate, with results that generally fall within 4-6% of lab values.  The difference can be significant for those who are calculating insulin doses based on blood glucose levels.  The inaccuracy can be even greater when the blood sugar is rising or falling quickly – something called “lag time”.  Because Libre measures glucose concentrations in interstitial fluid in the fat layer rather than in the bloodstream directly, it takes time for changes in blood sugar to show up on the sensor.  Think of it this way:  Fingerstick blood glucose always gets the front seat in a roller coaster, fat-layer glucose always gets the back seat.  When the coaster is climbing, the glucose in the fingerstick will be higher than the fat layer.  When the coaster is dropping, the fingerstick will be lower.

 

Even if the accuracy of Libre matched the best blood glucose meters, there are still times when fingersticks are going to be needed:

 

  • During the 12-hour warmup period
  • When physical symptoms don’t match what Libre is displaying
  • Any time the receiver displays “Check Blood Glucose”
  • If the sensor comes off the skin accidentally
  • In the event the receiver is lost/broken or sensors are temporarily unavailable

 

And for many of us who have performed more fingersticks than we’d care to count over the years, there is a trust issue.  The clients we have in Europe who use Libre still check their blood sugar the old fashioned way just to make sure the Libre is working properly.  Some check a few times a day, some a few times a week, and others just during the first couple of weeks.

 

Super for Who?

 

Bottom line:  If you currently use a CGM and rely on it to warn you when your glucose is getting out of range, Libre is probably not for you.  If you’re not using a CGM and would benefit from being warned when your is getting getting out of range, then you should check into using a CGM other than Libre.  If you like the idea of having frequent BG data along with trending information but don’t want the alarms/alert intrinsic to current CGM systems, Libre may be a good choice.

 

For those who just rely on fingersticks and are susceptible to hypoglycemia, heck – even if you just detest doing fingersticks, Libre can be highly beneficial.  In addition to being a quick and frequent source of reasonably accurate glucose data, Libre provides that all-important direction you’re headed.  With all the decisions we make throughout the day related to our diabetes, knowing both the current glucuose value and where it’s headed lets us make much better decisions.  Think about it:  If your glucose is 118 and you’re about to exercise, take a test, drive a car, perform open-heart surgery, or just go to sleep, you can make prepare better knowing if you’re rising, falling or stable.

 

Super Summation

 

On the plus side, Libre has accuracy comparable to Dexcom, it is very easy to use, and does not require any fingersticks.  It provides a wealth of valuable information to the user with minimal discomfort and inconvience.

 

On the downside, Libre lacks the alert features incumbent to other CGM systems, and its accuracy, while good, is not as good as most modern fingerstick meters.

 

A prescription will be required to obtain Libre in the US.  It is approved for age 18 plus, but it can be used by children when prescribed “off-label” by a physician.

 

To learn more and for product updates, Abbott has set up a website:  www.freestylelibre.us.  If you decide to give Libre a try and want to learn how to react/adjust to the trending information and interpret the downloadable reports, give our office a call (610-642-6055).

 

To use new technology and really benefit from it… now that’s a SUPER combination!

By | 2017-11-21T14:55:30+00:00 November 18th, 2017|November 2017 Newsletter, Thinking Like A Pancreas Blog|5 Comments

About the Author:

5 Comments

  1. Chole Gel November 20, 2017 at 10:50 am - Reply

    Thanks, Dr. Gary for providing details about Abbott’s FreeStyle Libre sensor.Certainly, this will help patients in making an informed decision whether Libre sensor is a right option for them or not. We are using Ambrosia’s NightRider BluCon since June, 17 and it is working like a charm. we are using it with xDrip+ app but could also be used with LinkBluCon app to see glucose reading every 5 minutes on the phone. In the recently released beta app of LinkBluCon iOS version user can also share reading on Apple Health kit while if you use xDrip+ then you can see glucose reading of your kid even when he is school, by using an app from NightScout.

  2. Joe Short November 20, 2017 at 11:16 am - Reply

    Good to see a well written article about Libre. I have been using Libre for 2 years and am active in an independent worldwide Facebook group of over 12,000 Libre users; about 9,000 take part at least once per month. We learn a great deal – both the good and the bad (thankfully not much of the latter!) Most PWD, both T1 & T2, consider it to be life-changing.Our biggest problems at the moment come from Abbott not being able to provide a reliable supply in the U.K. due to over-demand.
    We have discovered a number of workarounds which hopefully will also work in the USA version. An Italian company has developed an Android app that will read the sensor during the initial settling-in period – we don’t like losing that hour even if slightly less accurate (we know, so can compensate for dosing). It also gives an extra 12 hours at the end – we use this to save even more fingerpricks by using 2 concurrent sensors at changeover. We also insert 12-24 hours before activation. This allows insertion trauma to settle while not taking up sensor operation time – no need for your 12 hour loss! And we certainly can link data to carers and loved ones – even with Abbott apps!

  3. Joe Short November 20, 2017 at 11:32 am - Reply

    I should add to my previous comment that many consider the accuracy and safety provided by Libre to be far superior to BGM. Two critical aspects are often ignored when accuracy comparisons are made.
    The accuracy measurements are made with single spot readings. The BGM values depend upon “perfect” user precautions and sterile techniques. On the latter, independent tests show actual home use of BGM has current meters struggling to meet a 15% accuracy – one evaluation had less than 1/3rd complying with requirements.
    The other major difference is that the Libre takes a reading every minute. It stores less but uses 15 individual readings to provide the trend which you do highlight as one of the major advantages. As well as that we see the daily graph – again allowing us to judge from multiple individual readings about direction.
    Another major advantage is the provision of AGP graphs – a marvellous aid to Diabetes management.

  4. Denis B November 21, 2017 at 9:04 pm - Reply

    I’ve been using the Freestyle Libre for the past month and have managed to wreck two sensors in that time – once by bumping into a door frame, and the other by rolling over in my sleep. Be very careful when positioning the sensor to avoid these (very expensive) circumstances.

    Other than this issue, I’ve been very happy with the Freestyle Libre. My endocrinologist is able to see my BG trends for the entire day and has made several insulin dosage changes with the data.

    • alicia downs December 6, 2017 at 6:03 pm - Reply

      Thanks for the advice on the fragility of the libre Denis!

Leave A Comment